BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Date M, Matsuzaki K, Matsushita M, Tahashi Y, Furukawa F, Inoue K. Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury. Gut. 2000;46:719-724. [PMID: 10764719 DOI: 10.1136/gut.46.5.719] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Matsuzaki K. Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells. Cell Tissue Res 2012;347:225-43. [PMID: 21626291 DOI: 10.1007/s00441-011-1178-6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
2 Higashi K, Tomigahara Y, Shiraki H, Miyata K, Mikami T, Kimura T, Moro T, Inagaki Y, Kaneko H. A novel small compound that promotes nuclear translocation of YB-1 ameliorates experimental hepatic fibrosis in mice. J Biol Chem 2011;286:4485-92. [PMID: 21115500 DOI: 10.1074/jbc.M110.151936] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
3 Luo H, Li L, Tang J, Zhang F, Zhao F, Sun D, Zheng F, Wang X. Amygdalin inhibits HSC-T6 cell proliferation and fibrosis through the regulation of TGF-β/CTGF. Mol Cell Toxicol 2016;12:265-71. [DOI: 10.1007/s13273-016-0031-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
4 Pizano-Martínez O, Yañez-Sánchez I, Alatorre-Carranza P, Miranda-Díaz A, Ortiz-Lazareno PC, García-Iglesias T, Daneri-Navarro A, Mercado MVD, Fafutis-Morris M, Delgado-Rizo V. YKL-40 expression in CD14+ liver cells in acute and chronic injury. World J Gastroenterol 2011; 17(33): 3830-3835 [PMID: 21987626 DOI: 10.3748/wjg.v17.i33.3830] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
5 Boye A, Wu C, Jiang Y, Wang J, Wu J, Yang X, Yang Y. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism. Journal of Ethnopharmacology 2015;169:219-28. [DOI: 10.1016/j.jep.2015.04.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
6 Feng G, Long Y, Peng J, Li Q, Cui Z. Transcriptomic characterization of the dorsal lobes after hepatectomy of the ventral lobe in zebrafish. BMC Genomics 2015;16:979. [PMID: 26584608 DOI: 10.1186/s12864-015-2145-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Crespo Yanguas S, Cogliati B, Willebrords J, Maes M, Colle I, van den Bossche B, de Oliveira CP, Andraus W, Alves VA, Leclercq I. Experimental models of liver fibrosis. Arch Toxicol. 2016;90:1025-1048. [PMID: 26047667 DOI: 10.1007/s00204-015-1543-4] [Cited by in Crossref: 108] [Cited by in F6Publishing: 106] [Article Influence: 18.0] [Reference Citation Analysis]
8 Macias-Silva M, Li W, Leu JI, Crissey MA, Taub R. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration. J Biol Chem. 2002;277:28483-28490. [PMID: 12023281 DOI: 10.1074/jbc.m202403200] [Cited by in Crossref: 73] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
9 Yoshida K, Matsuzaki K. Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries. Front Physiol. 2012;3:53. [PMID: 22457652 DOI: 10.3389/fphys.2012.00053] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 8.4] [Reference Citation Analysis]
10 Flisiak R, Jaroszewicz J, Łapiński TW, Flisiak I, Rogalska M, Prokopowicz D. Plasma transforming growth factor β1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B. Regulatory Peptides 2005;131:54-8. [DOI: 10.1016/j.regpep.2005.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
11 Meurer SK, Karsdal MA, Weiskirchen R. Advances in the clinical use of collagen as biomarker of liver fibrosis. Expert Rev Mol Diagn 2020;20:947-69. [PMID: 32865433 DOI: 10.1080/14737159.2020.1814746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Parlakgumus A, Colakoglu T, Kayaselcuk F, Colakoglu S, Ezer A, Calıskan K, Karakaya J, Yildirim S. Two drugs with paradoxical effects on liver regeneration through antiangiogenesis and antifibrosis: Losartan and Spironolactone: a pharmacologic dilemma on hepatocyte proliferation. J Surg Res 2013;179:60-5. [PMID: 22989552 DOI: 10.1016/j.jss.2012.08.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Turk O, Badak B, Ates E, Dundar E, Sutken E. The role of growth factors on hepatic damage in rats with obstructive jaundice. Springerplus 2016;5:1274. [PMID: 27540507 DOI: 10.1186/s40064-016-2919-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
14 Matsuzaki K, Seki T, Okazaki K. TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases. J Gastroenterol 2014;49:971-81. [PMID: 24263677 DOI: 10.1007/s00535-013-0910-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
15 Yoshida K, Murata M, Yamaguchi T, Matsuzaki K, Okazaki K. Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions. J Clin Med 2016;5:E7. [PMID: 26771649 DOI: 10.3390/jcm5010007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
16 Hamzavi J, Ehnert S, Godoy P, Ciuclan L, Weng H, Mertens PR, Heuchel R, Dooley S. Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice. J Cell Mol Med 2008;12:2130-44. [PMID: 18266971 DOI: 10.1111/j.1582-4934.2008.00262.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
17 Wu S, Wang Y, Zhang M, Wang M, He JQ. Transforming growth factor-beta 1 polymorphisms and anti-tuberculosis drug-induced liver injury. Polymorphisms in TGFβ1 and its relationship with anti-tuberculosis drug-induced liver injury. Therapie 2019;74:399-406. [PMID: 30093157 DOI: 10.1016/j.therap.2018.07.003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Wu L, Lu I, Chung C, Wu H, Liu Y. Antiproliferative mechanisms of quercetin in rat activated hepatic stellate cells. Food Funct 2011;2:204. [DOI: 10.1039/c0fo00158a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
19 Yoshida K, Murata M, Yamaguchi T, Matsuzaki K. TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review). Int J Oncol 2014;45:1363-71. [PMID: 25050845 DOI: 10.3892/ijo.2014.2552] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 10.9] [Reference Citation Analysis]
20 Yoshida K, Matsuzaki K. Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries. Front Physiol. 2012;3:53. [PMID: 22457652 DOI: 10.3389/fphys]] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Hu PF, Chen H, Zhong W, Lin Y, Zhang X, Chen YX, Xie WF. Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats. J Hepatol. 2009;51:102-113. [PMID: 19446913 DOI: 10.1016/j.jhep.2009.02.025] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
22 Chen HN, Fan S, Weng CF. Down-regulation of TGFbeta1 and leptin ameliorates thioacetamide-induced liver injury in lipopolysaccharide-primed rats. J Endotoxin Res. 2007;13:176-188. [PMID: 17621560 DOI: 10.1177/0968051907081102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
23 Ren S, Chen J, Wang Q, Li X, Xu Y, Zhang X, Mu Y, Zhang H, Huang S, Liu P. MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis. Hepatol Int 2019;13:814-25. [PMID: 31643031 DOI: 10.1007/s12072-019-09993-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Chi CH, Liu IL, Lo WY, Liaw BS, Wang YS, Chi KH. Hepatocyte growth factor gene therapy prevents radiation-induced liver damage. World J Gastroenterol 2005; 11(10): 1496-1502 [PMID: 15770726 DOI: 10.3748/wjg.v11.i10.1496] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
25 Bauer M, Schuppan D. TGF-beta1 in liver fibrosis: time to change paradigms? FEBS Lett. 2001;502:1-3. [PMID: 11478937 DOI: 10.1016/s0014-5793(01)02655-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
26 Qiu J, Liu Z, Da L, Li Y, Xuan H, Lin Q, Li F, Wang Y, Li Z, Zhao M. Overexpression of the gene for transmembrane 4 superfamily member 4 accelerates liver damage in rats treated with CCl4. Journal of Hepatology 2007;46:266-75. [DOI: 10.1016/j.jhep.2006.08.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
27 Gao L, Utsumi T, Tashiro K, Liu B, Zhang D, Swenson ES, Iwakiri Y. Reticulon 4B (Nogo-B) facilitates hepatocyte proliferation and liver regeneration in mice. Hepatology 2013;57:1992-2003. [PMID: 23299899 DOI: 10.1002/hep.26235] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
28 Okada Y, Tsuzuki Y, Hokari R, Miyazaki J, Matsuzaki K, Mataki N, Komoto S, Watanabe C, Kawaguchi A, Nagao S. Pressure loading and ethanol exposure differentially modulate rat hepatic stellate cell activation. J Cell Physiol. 2008;215:472-480. [PMID: 18064666 DOI: 10.1002/jcp.21329] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
29 Yoshida K, Matsuzaki K, Mori S, Tahashi Y, Yamagata H, Furukawa F, Seki T, Nishizawa M, Fujisawa J, Okazaki K. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol. 2005;166:1029-1039. [PMID: 15793284 DOI: 10.1016/s0002-9440(10)62324-3] [Cited by in Crossref: 120] [Cited by in F6Publishing: 62] [Article Influence: 7.5] [Reference Citation Analysis]
30 Sanz S, Pucilowska JB, Liu S, Rodríguez-Ortigosa CM, Lund PK, Brenner DA, Fuller CR, Simmons JG, Pardo A, Martínez-Chantar ML. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut. 2005;54:134-141. [PMID: 15591519 DOI: 10.1136/gut.2003.024505] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.0] [Reference Citation Analysis]
31 Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, ten Dijke P, Gressner AM. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett. 2001;502:4-10. [PMID: 11478938 DOI: 10.1016/s0014-5793(01)02656-4] [Cited by in Crossref: 137] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
32 Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology. 2002;35:49-61. [PMID: 11786959 DOI: 10.1053/jhep.2002.30083] [Cited by in Crossref: 134] [Cited by in F6Publishing: 143] [Article Influence: 7.1] [Reference Citation Analysis]
33 Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 2003;33:105-136. [PMID: 12708612 DOI: 10.1080/713611034] [Cited by in Crossref: 1022] [Cited by in F6Publishing: 880] [Article Influence: 60.1] [Reference Citation Analysis]
34 Park J, Jeong D, Park H, Son K, Shin D, Do S, Yang H, Yuan D, Hong I, Goo M, Lee H, Ki M, Ishigami A, Jeong K. Hepatoprotective effect of Arazyme on CCl4-induced acute hepatic injury in SMP30 knock-out mice. Toxicology 2008;246:132-42. [DOI: 10.1016/j.tox.2008.01.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
35 Jeong W, Do S, Yun H, Song B, Kim S, Kwak W, Yoo S, Park H, Jeong K. Hypoxia potentiates transforming growth factor-beta expression of hepatocyte during the cirrhotic condition in rat liver. Liver Int 2004;24:658-68. [DOI: 10.1111/j.1478-3231.2004.0961.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
36 Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki Y. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology. 2003;38:879-889. [PMID: 14512875 DOI: 10.1002/hep.1840380414] [Cited by in Crossref: 122] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
37 Azimifar SB, Nagaraj N, Cox J, Mann M. Cell-type-resolved quantitative proteomics of murine liver. Cell Metab 2014;20:1076-87. [PMID: 25470552 DOI: 10.1016/j.cmet.2014.11.002] [Cited by in Crossref: 96] [Cited by in F6Publishing: 92] [Article Influence: 16.0] [Reference Citation Analysis]
38 Chen L, Zhang W, Zhou Q, Yang H, Liang H, Zhang B, Long X, Chen X. HSCs play a distinct role in different phases of oval cell-mediated liver regeneration: HSCS PLAY A DISTINCT ROLE IN DIFFERENT PHASES. Cell Biochem Funct 2012;30:588-96. [DOI: 10.1002/cbf.2838] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]